Clinical Trial Update: Induction Lorlatinib in Stage III Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating induction lorlatinib for Stage III non-small cell lung cancer, including patients undergoing surgery. The study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• lorlatinib (lorlatinib)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Stage III NSCLC, Surgery | Phase 2 | Status: ACTIVE_NOT_RECRUITING